Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

Colorectal Neoplasms

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 51 articles: HTML format

Single Articles

February 2025
1. KLEEBAYOON A, Wiwanitkit V
   Implications of Artificial Intelligence for Colorectal Cancer: Correspondence.
   J Surg Oncol. 2025 Feb 4. doi: 10.1002/jso.28062.
   PubMed    
   
   
   January 2025
2. DIERGAARDE B, Young G, Hall DW, Mazloom A, et al
   Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The alpha-CORRECT Study.
   J Surg Oncol. 2025 Jan 25. doi: 10.1002/jso.27989.
   PubMed     Abstract available
   
   
   
3. SOOP M, Anderin K, Syk E, Nygren J, et al
   Colorectal Cancer Surgery at a Regional Cold Site Centre During the SARS-CoV-2 Pandemic: A Comparison With Prepandemic Practices.
   J Surg Oncol. 2025 Jan 21. doi: 10.1002/jso.28094.
   PubMed     Abstract available
   
   
   
4. BAKILLAH E, Rosenthal JW, Syvyk S, Wirtalla C, et al
   Colorectal Cancer and Quality of Life: A Medicare Advantage Study by Race, Ethnicity, and Language.
   J Surg Oncol. 2025 Jan 13. doi: 10.1002/jso.28005.
   PubMed     Abstract available
   
   
   December 2024
5. GRUNHUT J, Newland JJ, Brown RF
   Implications of Artificial Intelligence for Colorectal Cancer in Young Populations.
   J Surg Oncol. 2024 Dec 9. doi: 10.1002/jso.28036.
   PubMed     Abstract available
   
   
   
6. BUCHHEIT JT, Janczewski LM, Wells A, Hardy AN, et al
   Omission of Chemoradiation in Locally Advanced Rectal Adenocarcinoma: Evaluation of PROSPECT in a National Database.
   J Surg Oncol. 2024;130:1662-1673.
   PubMed     Abstract available
   
   
   
7. MILANZI E, Pelly RM, Hayes IP, Gibbs P, et al
   Accuracy of Baseline Magnetic Resonance Imaging for Staging Rectal Cancer Patients Proceeding Directly to Surgery.
   J Surg Oncol. 2024;130:1674-1682.
   PubMed     Abstract available
   
   
   
8. MOAVEN O, Mainali BB, Valenzuela CD, Russell G, et al
   Prognostic implications of margin status in association with systemic treatment in a cohort study of patients with resection of colorectal liver metastases.
   J Surg Oncol. 2024;130:1654-1661.
   PubMed     Abstract available
   
   
   November 2024
9. L'HUILLIER JC, Boccardo JD, Berkebile M, Woodward JM, et al
   No Difference in Perioperative Outcomes Following Colorectal Cancer Resection Between Flagship and Non-Flagship Hospitals in New York State.
   J Surg Oncol. 2024 Nov 28. doi: 10.1002/jso.27949.
   PubMed     Abstract available
   
   
   
10. LAI F, Li S, Shen Z
    Comment on "Dense Tumor-Infiltrating Lymphocytes (TILs) in Liver Metastasis From Colorectal Cancer Are Related to Improved Overall Survival".
    J Surg Oncol. 2024 Nov 28. doi: 10.1002/jso.27968.
    PubMed    
    
    
    
11. ADERIBIGBE AS, Dare AJ, Kalvin HL, Olasehinde O, et al
    Analysis of Risk Factors, Treatment Patterns, and Survival Outcomes After Emergency Presentation With Colorectal Cancer: A Prospective Multicenter Cohort Study in Nigeria.
    J Surg Oncol. 2024 Nov 21. doi: 10.1002/jso.27878.
    PubMed     Abstract available
    
    
    
12. VAN DEN HEUVEL TBM, Lurvink RJ, Rovers KPB, van Hellemond IEG, et al
    Systemic chemotherapy in addition to CRS-HIPEC for colorectal peritoneal metastases: A critical systematic review on the impact on overall survival.
    J Surg Oncol. 2024;130:1378-1389.
    PubMed     Abstract available
    
    
    October 2024
13. GOERE D, Kusamura S, Lurvink RJ, Cinquini M, et al
    Guidelines for the Prophylaxis and Treatment of Peritoneal Metastases From Colorectal Cancer: A GRADE-Approach for Evidence Evaluation and Recommendations.
    J Surg Oncol. 2024 Oct 25. doi: 10.1002/jso.27957.
    PubMed     Abstract available
    
    
    
14. LARSEN SG, Graf W, Larsen RH, Revheim ME, et al
    Eighteen-Months Safety and Efficacy Following Intraperitoneal Treatment With (224)Radium-Labeled Microparticles After CRS-HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer.
    J Surg Oncol. 2024 Oct 20. doi: 10.1002/jso.27897.
    PubMed     Abstract available
    
    
    
15. MKABAAH LB, Davey MG, Kerin EP, Ryan OK, et al
    Comparing Open, Laparoscopic and Robotic Liver Resection for Metastatic Colorectal Cancer-A Systematic Review and Network Meta-Analysis.
    J Surg Oncol. 2024 Oct 10. doi: 10.1002/jso.27909.
    PubMed     Abstract available
    
    
    September 2024
16. ZHANG CJ
    Commentary on "Preoperative Chemotherapy Response and Survival in Patients With Colorectal Cancer Peritoneal Metastases".
    J Surg Oncol. 2024 Sep 24. doi: 10.1002/jso.27929.
    PubMed    
    
    
    
17. JACKSON AT, Megafu O, Abdullahi D, Amajoyi R, et al
    Colorectal cancer care continuum: Navigating screening, treatment, and outcomes disparities.
    J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27848.
    PubMed     Abstract available
    
    
    
18. HU Q, Yang X
    Impact of Comprehensive Geriatric Assessment on Treatment Strategies and Complications in Older Adults With Colorectal Cancer Considering Surgery.
    J Surg Oncol. 2024 Sep 10. doi: 10.1002/jso.27892.
    PubMed    
    
    
    
19. RAY-OFFOR E, Garoufalia Z, Emile SH, Horesh N, et al
    Heterogeneity in survival within age groups of early-onset colorectal cancer patients: A National Cancer Database analysis.
    J Surg Oncol. 2024 Sep 5. doi: 10.1002/jso.27754.
    PubMed     Abstract available
    
    
    
20. MAINALI BB, Valenzuela CD, Moaven O, Stauffer JA, et al
    Resection versus resection with ablation: Analysis from the colorectal liver operative metastasis international collaborative.
    J Surg Oncol. 2024;130:516-522.
    PubMed     Abstract available
    
    
    
21. ARAUJO SEA, Seid VE, Portilho AS, Horcel LA, et al
    Robot-assisted transanal minimally invasive surgery for the treatment of rectal adenocarcinoma.
    J Surg Oncol. 2024;130:844-845.
    PubMed     Abstract available
    
    
    
22. GERBASI LS, Tustumi F, Seid VE, Araujo SEA, et al
    Does Tri-Staple technology reduce the risk of anastomotic leakage in colorectal surgery? A propensity score matching analysis.
    J Surg Oncol. 2024;130:830-837.
    PubMed     Abstract available
    
    
    
23. VALADAO M, Riechelmann RP, Silva JACE, Mali J, et al
    Brazilian Society of Surgical Oncology: Guidelines for the management of anal canal cancer.
    J Surg Oncol. 2024;130:810-829.
    PubMed     Abstract available
    
    
    August 2024
24. KAISER KN, Hughes AJ, Yang AD, Turk AA, et al
    Accuracy and consistency of publicly available Large Language Models as clinical decision support tools for the management of colon cancer.
    J Surg Oncol. 2024 Aug 19. doi: 10.1002/jso.27821.
    PubMed     Abstract available
    
    
    
25. MOMOSE H, Sugimoto K, Irie T, Nomura S, et al
    Prognostic utility of circulating tumor DNA methylation analysis in stage IV colorectal cancer.
    J Surg Oncol. 2024 Aug 19. doi: 10.1002/jso.27824.
    PubMed     Abstract available
    
    
    
26. SHOU M, Habib DRS, Idrees K, Hawkins A, et al
    Impact of neoadjuvant immunotherapy on postoperative complications after surgery for rectal cancer.
    J Surg Oncol. 2024;130:322-328.
    PubMed     Abstract available
    
    
    July 2024
27. KHORFAN R, Sedighim S, Caba-Molina D, Tran TB, et al
    Improved survival with immunotherapy for microsatellite unstable colorectal cancer with peritoneal metastases.
    J Surg Oncol. 2024 Jul 31. doi: 10.1002/jso.27740.
    PubMed     Abstract available
    
    
    
28. YAO X, Zhou Z, Mao S, Cao J, et al
    Lymph node metastasis detection using artificial intelligence in T1 colorectal cancer: A comprehensive systematic review.
    J Surg Oncol. 2024 Jul 17. doi: 10.1002/jso.27766.
    PubMed     Abstract available
    
    
    
29. XIA L, Yin R, Mao L, Shi X, et al
    Prevalence and impact of frailty in patients undergoing colorectal cancer surgery: A systematic review and meta-analysis based on modified frailty index.
    J Surg Oncol. 2024 Jul 17. doi: 10.1002/jso.27778.
    PubMed     Abstract available
    
    
    
30. TINSLEY N, O'Dwyer ST, Nagaraju R, Chakrabarty B, et al
    Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastases.
    J Surg Oncol. 2024 Jul 16. doi: 10.1002/jso.27776.
    PubMed     Abstract available
    
    
    
31. SCHABL L, Connelly TM, de Camargo MGM, Sancheti H, et al
    Crohn's disease-related versus sporadic colorectal cancer: A stage-matched case-control study based on four decades of experience.
    J Surg Oncol. 2024 Jul 14. doi: 10.1002/jso.27768.
    PubMed     Abstract available
    
    
    
32. VAZ DA SILVA DG, de Ribeiro HSC, Dos Santos GO, Lindote MVN, et al
    Dense tumor-infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival.
    J Surg Oncol. 2024 Jul 1. doi: 10.1002/jso.27759.
    PubMed     Abstract available
    
    
    
33. RAY-OFFOR E, Nagarajan A, Horesh N, Emile SH, et al
    Effect of neoadjuvant therapy regimens on lymph nodes yield in rectal cancer.
    J Surg Oncol. 2024;130:125-132.
    PubMed     Abstract available
    
    
    
34. CAI M, Blythe N, Jo A, Wong SL, et al
    Electronic health record-integrated questionnaires in colorectal surgery patients as a new standard: Could preoperative bowel function be used to predict postoperative patient-reported outcomes?
    J Surg Oncol. 2024;130:133-139.
    PubMed     Abstract available
    
    
    
35. DAVIS JMK, Niazi MKK, Ricker AB, Tavolara TE, et al
    Predicting response to neoadjuvant chemotherapy for colorectal liver metastasis using deep learning on prechemotherapy cross-sectional imaging.
    J Surg Oncol. 2024;130:93-101.
    PubMed     Abstract available
    
    
    June 2024
36. SUGIYAMA M, Nishijima TF, Kasagi Y, Uehara H, et al
    Impact of comprehensive geriatric assessment on treatment strategies and complications in older adults with colorectal cancer considering surgery.
    J Surg Oncol. 2024 Jun 16. doi: 10.1002/jso.27736.
    PubMed     Abstract available
    
    
    
37. HERNANDEZ MC, Fan D, Sandhu J, Mahuron K, et al
    Recurrence patterns after complex multimodality therapy and hepatic arterial infusion for colorectal liver metastases: A reflection of biology and technique.
    J Surg Oncol. 2024;129:1254-1264.
    PubMed     Abstract available
    
    
    
38. SURAJU MO, Freischlag K, McKeen A, Nayyar A, et al
    Evaluation of association between center colorectal neuroendocrine neoplasm volume and survival among patients with colorectal neuroendocrine carcinoma.
    J Surg Oncol. 2024;129:1449-1455.
    PubMed     Abstract available
    
    
    
39. CAI M, Cotter RR, Wong SL, Mayo SW, et al
    Evaluating clinical practice guidelines for the management of rectal cancer: Did they get it RIGHT?
    J Surg Oncol. 2024;129:1475-1480.
    PubMed     Abstract available
    
    
    May 2024
40. BENDARI A, Hammoud H, Kumar SK, Harshan M, et al
    Commentary on Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
    J Surg Oncol. 2024 May 22. doi: 10.1002/jso.27669.
    PubMed    
    
    
    
41. BREWER J, Kamara M, Huebner M, Taxakis E, et al
    Operative trends following the adoption of nonoperative management of rectal cancer.
    J Surg Oncol. 2024;129:1139-1149.
    PubMed     Abstract available
    
    
    
42. LABADIE KP, Olson KA, Sun SH, Ituarte PHG, et al
    Outcomes of rectal cancer patients who refuse surgery after incomplete clinical response to neoadjuvant therapy.
    J Surg Oncol. 2024;129:1131-1138.
    PubMed     Abstract available
    
    
    
43. KAZI M, Choubey K, Patil P, Jaiswal D, et al
    Patient reported outcomes after multivisceral resection for advanced rectal cancers in female patients.
    J Surg Oncol. 2024;129:1106-1112.
    PubMed     Abstract available
    
    
    
44. NAKAO E, Honda M, Uesugi N, Osakabe M, et al
    Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy.
    J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27662.
    PubMed     Abstract available
    
    
    April 2024
45. GONCALVES AFK, de Barros ABD, Castro LM, Dutra JB, et al
    Accuracy of surgeons for predicting radiological sarcopenia in colorectal cancer surgery.
    J Surg Oncol. 2024 Apr 18. doi: 10.1002/jso.27652.
    PubMed     Abstract available
    
    
    
46. BEPPU T, Yamamura K, Imai K, Hayashi H, et al
    Recurrence-risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases.
    J Surg Oncol. 2024;129:893-900.
    PubMed     Abstract available
    
    
    
47. STEVANATO FILHO PR, Bezerra TS, Marques TMDM, Nahime RH, et al
    A precise approach to robotic intracorporeal rectal transection and hand-sewn purse-string anastomosis for low anterior resection.
    J Surg Oncol. 2024;129:939-944.
    PubMed     Abstract available
    
    
    
48. WEHRLE CJ, Woo K, Chang J, Gamaleldin M, et al
    Impact of neoadjuvant therapy on nodal harvest in clinical stage III rectal cancer: Establishing optimum cut-offs by disease response.
    J Surg Oncol. 2024;129:945-952.
    PubMed     Abstract available
    
    
    
49. ALI D, Syed M, Gamboa AC, Hawkins AT, et al
    Association of omental pedicled flap with anastomotic leak following low anterior resection for rectal cancer.
    J Surg Oncol. 2024;129:930-938.
    PubMed     Abstract available
    
    
    March 2024
50. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    A national database analysis of the evolution of outcomes of surgery for anal melanoma.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27631.
    PubMed     Abstract available
    
    
    
51. GKEKAS I, Jan N, Kaprio T, Beilmann-Lehtonen I, et al
    Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy: A European multicenter cohort study.
    J Surg Oncol. 2024 Mar 12. doi: 10.1002/jso.27619.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.